Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

atrophoderma of Pierini and Pasini - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

atrophoderma of Pierini and Pasini

MONDO:0022513

Also known as:congenital atrophoderma of Pasini and Pieriniidiopathic atrophoderma of Pasini and Pierini

Overview

Atrophoderma of Pierini and Pasini is thought to possibly represent a late stage of morphea a type of localized scleroderma. Signs and symptoms ofatrophoderma of Pierini and Pasini include multiple oval, darkened (hyperpigmented) plaques in which tissue under the skin breaks downso that there is a depression (dent) within the skin. Some findings suggest that atrophoderma of Pierini and Pasini may be associated with B burgdorferi, a bacteria that causesLyme disease, in some cases.

ResearchLimited published research (6 articles)

Prognosis

Estimated prevalence: <1 in 1,000,000 (VERY_RARE).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for atrophoderma of Pierini and Pasini.

6 publications have been identified in PubMed for atrophoderma of Pierini and Pasini. Research spans Case Report / Case Series (83%) and Other (17%).

Recent Publications

Syed HA (2026). [PMID: 30085611](https://pubmed.ncbi.nlm.nih.gov/30085611/). *Unknown Journal*. [Other]
Ceballos-Pérez M (2025). [PMID: 39949423](https://pubmed.ncbi.nlm.nih.gov/39949423/). *Cureus*. [Case Report / Case Series]
Jaiswal S (2025). [PMID: 41078424](https://pubmed.ncbi.nlm.nih.gov/41078424/). *JAAD Case Rep*. [Case Report / Case Series]
Chiba K (2025). [PMID: 40979044](https://pubmed.ncbi.nlm.nih.gov/40979044/). *Cureus*. [Case Report / Case Series]
Gambichler T (2025). [PMID: 40397155](https://pubmed.ncbi.nlm.nih.gov/40397155/). *Dermatologie (Heidelb)*. [Case Report / Case Series]
Pathak R (2025). [PMID: 40123740](https://pubmed.ncbi.nlm.nih.gov/40123740/). *Case Rep Dermatol Med*. [Case Report / Case Series]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:658810

GARD

Genetic and Rare Diseases Info Center

GARD:5866

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

atrophoderma of Pierini and Pasini

Overview

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team